Compounds > argipressin (4-9)
Page last updated: 2024-09-03

argipressin (4-9) and pyrrolidonecarboxylic acid

argipressin (4-9) has been researched along with pyrrolidonecarboxylic acid in 3 studies

Compound Research Comparison

Studies
(argipressin (4-9))		Trials
(argipressin (4-9))		Recent Studies (post-2010)
(argipressin (4-9))		Studies
(pyrrolidonecarboxylic acid)		Trials
(pyrrolidonecarboxylic acid)		Recent Studies (post-2010) (pyrrolidonecarboxylic acid)
36003,005101671

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fahrenholz, F; Gerstberger, R; Jurzak, M1
Chepkova, AN; Gudasheva, TA; Kapai, NA; Morozova, AA; Skrebitskii, VG1
Jiang, XG; Lu, W; Xie, YL1

Other Studies

3 other study(ies) available for argipressin (4-9) and pyrrolidonecarboxylic acid

ArticleYear
Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
    Journal of neuroendocrinology, 1993, Volume: 5, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Arginine Vasopressin; Autoradiography; Brain; Brain Chemistry; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Immunohistochemistry; Male; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Sulfur Radioisotopes; Vasopressins

1993
Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices.
    Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:2

    Topics: Animals; Arginine Vasopressin; Dipeptides; Electric Stimulation; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Nootropic Agents; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar

2004
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
    Behavioural brain research, 2006, Oct-02, Volume: 173, Issue:1

    Topics: Animals; Arginine Vasopressin; Avoidance Learning; Drug Carriers; Drug Delivery Systems; Male; Memory; Memory Disorders; Mice; Nanostructures; Nootropic Agents; Oligopeptides; Particle Size; Peptide Fragments; Polyethylene Glycols; Pyrrolidonecarboxylic Acid; Random Allocation; Scopolamine; Serum Albumin, Bovine

2006